1
[1] Debie, A., Nigusie, A., Gedle, D., Khatri, R. B., & Assefa, Y. (2024). Building a resilient health system for universal health coverage and health security: a systematic review. Global Health Research and Policy, 9(1), 2.
2
[2] Haemmerli, M., Asante, A., Susilo, D., Satrya, A., Fattah, R. A., Cheng, Q., ... & Wiseman, V. (2022). Using measures of quality of care to assess equity in health care funding for primary care: analysis of Indonesian household data. BMC health services research, 22(1), 1349.
3
[3] Nugroho, S. T., Ahsan, A., Kusuma, D., Adani, N., Irawaty, D. K., Amalia, N., & Hati, S. R. H. (2023). Income disparity and healthcare utilization: lessons from Indonesia’s national health insurance claim data. Asian Pacific journal of cancer prevention: APJCP, 24(10), 3397.
4
[4] I. N. Nabila, M. B. Qomaruddin, and S. Widati. (2026). Promoting Equity in Public Health: Addressing Healthcare Utilization Disparities in Indonesia, JPK, vol. 14, no. SI1, pp. 163–175.
5
[5] O'connell, M., Hafidz, F., Saragih, S., Cashin, C., Nugroho, A., Hatt, L., ... & Pambudi, I. (2025). The influence of provider payment mechanisms on TB service provider behavior in Indonesia: insights from National Health Insurance data and provider perspectives. Frontiers in Public Health, 13, 1396596.
6
[6] Schaefers, J., Wenang, S., Afdal, A., Mukti, A. G., Sundari, S., & Haier, J. (2022). Population-based study on coverage and healthcare processes for cancer during implementation of national healthcare insurance in Indonesia. The Lancet Regional Health-Southeast Asia, 6.
7
[7] Deviandri, R., van der Veen, H. C., Lubis, A. M., Utoyo, G. A., van den Akker-Scheek, I., & Postma, M. J. (2022). Burden and cost of anterior cruciate ligament reconstruction and reimbursement of its treatment in a developing country: an observational study in Indonesia. ClinicoEconomics and Outcomes Research, 479-486.
8
[8] Purba, A. K. R., Mariana, N., Aliska, G., Wijaya, S. H., Wulandari, R. R., Hadi, U., ... & Postma, M. J. (2020). The burden and costs of sepsis and reimbursement of its treatment in a developing country: An observational study on focal infections in Indonesia. International Journal of Infectious Diseases, 96, 211-218.
9
[9] Sunariyanti, E., Andayani, T. M., Endarti, D., & Puspandari, D. A. (2023). Cost analysis of chronic kidney disease patients in Indonesia. ClinicoEconomics and Outcomes Research, 621-629.
10
[10] Suryanegara, F. D. A., Iskandar, D., Ekaputra, E., Kuntjoro, E., Setiawan, D., Postma, M. J., & de Jong, L. A. (2025). Costs analysis of radiotherapy for breast cancer in Indonesia: a comparison between reimbursement tariffs and actual costs. BMC Health Services Research, 25(1), 766.
11
[11] Thaifur, A. Y. B. R., Maidin, M. A., Sidin, A. I., & Razak, A. (2021). How to detect healthcare fraud?“A systematic review”. Gaceta sanitaria, 35, S441-S449.
12
[12] Herey, P., & Temesvari, N. A. (2022). Determinants of Approval Claims at Hospital Among COVID-19 Patients. Media Kesehatan Masyarakat Indonesia, 18(2), 67-73.
13
[13] Mahardini, S. R., & Dachyar, M. (2020, October). The critical improvement of hospital claim fulfillment towards public insurance, using BPR and MIS approach. In 2020 3rd International Conference on Applied Engineering (ICAE) (pp. 1-6). IEEE.
14
[14] Fahlevi, H., Mulyany, R., Yasir, M., Mustika, V. M., Rahayu, M., & Dawood, R. (2021, December). Predicting Cost Recovery Rate of Inpatient Cases: the Application of Machine Learning Approaches. In 2021 International Conference on Decision Aid Sciences and Application (DASA) (pp. 1002-1006). IEEE.
15
[15] Laksana, M. A. C., Damayanti, N. A., Habibie, P. H., Suhargono, M. H., Erni, R. D., Santoso, B., ... & Zakiya, N. Z. (2025). Strengthening maternal referral systems during public health emergencies: insights from Indonesia's covid-19 response. Jurnal Ners, 20(2), 192.
16
[16] Hasnida, A., Kok, M. O., & Pisani, E. (2021). Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia. BMJ global health, 6(Suppl 3), e003663.
17
[17] Khoiri, A., Hidayat, W., Chalidyanto, D., & Suhariadi, F. (2020). Potential of hospital fraud in the Indonesia national health insurance era (a descriptive phenomenological research). Indian Journal of Forensic Medicine & Toxicology, 14(3), 1132-1136.
18
[18] Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of business research, 133, 285-296.
19
[19] Kresnowati, L., Suhartono, S., Shaluhiyah, Z., & Widjanarko, B. (2024). Finding the new potential research on diabetic kidney disease and hemodialysis in healthcare insurance databases: A bibliometric analysis. Narra J, 4(3), e827.
20
[20] L. Judijanto and Irmayanti. (2025). Health Insurance Policy and Public Health Governance in Southeast Asia: A Bibliometric Perspective, West Sci. Soc. Humanit. Stud., vol. 3, no. 10, pp. 1362–1375.
21
[21] Ratnasari, W., & Amriza, R. N. S. (2026). Exploring the Development of Bibliometric Research in Indonesia. Jurnal Ilmu Informasi, Perpustakaan, Dan Kearsipan, 28(1), 3.
22
[22] Board, E. (2019). Preparation for the high-level meeting of the United Nations General Assembly on universal health coverage. In Preparation for the high-level meeting of the United Nations General Assembly on universal health coverage.
23
[23] Fahlevi, H., Roli Ilhamsyah Putra, T., & Suryani Oktari, R. (2020). Predicting cost recovery rate of ischemic stroke patients: A potential application of big data analysis in Hospital. In Journal of Physics: Conference Series (Vol. 1500, No. 1, p. 012106). IOP Publishing.
24
[24] Darmawan, E. S., Hasibuan, S. R., Permanasari, V. Y., & Kusuma, D. (2025). Disparities in cancer care and outcomes by insurance membership type in Indonesia: a retrospective cross-sectional analysis of national health insurance claims, 2017–2022. BMJ open, 15(7), e096486.
25
[25] Darmawan, E. S., Permanasari, V. Y., Nisrina, L. V., Kusuma, D., Hasibuan, S. R., & Widyasanti, N. (2024). Behind the hospital ward: in-hospital mortality of type 2 diabetes mellitus patients in Indonesia (analysis of national health insurance claim sample data). International Journal of Environmental Research and Public Health, 21(5), 581.
26
[26] Munandar, A., Hasibuan, S. R., & Kusuma, D. (2025). Differences in Hemodialysis Claim Patterns Across Membership Types Among Patients With Renal Failure Based on National Health Insurance Data From 2017 to 2022: Cross-Sectional Analysis. JMIR Public Health and Surveillance, 11(1), e73731.
27
[27] Setiawan, E., Devine, A., Prameswary, H. D., Baird, J. K., Price, R., & Thriemer, K. (2025). Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset. BMJ Global Health, 10(5), e018255.
28
[28] Ramhi, R. N., Rahmatiqa, C., & Susilo, H. (2024). Factors Causing Pending Claims on BPJS Outpatients at Mutiara Bunda Mother and Child Hospital Year 2024. Journal of Medical Record and Infomation Technologi (JOMRIT), 2(2), 18-22.
29
[29] Emilya, M., Misnaniarti, R. A. S., & Pratomo, H. (2025). Managing Potential Fraud in Palembang Hospitals’ Health Insurance Implementation: A Qualitative Study in Indonesia. Jurnal Jaminan Kesehatan Nasional, 5(2), 278-293.
30
[30] I. Adrianto and Sumarno.(2024). Legal Protection for Hospitals Against Delay in Payment of Claims by BPJS. International Journal of Society and Law, 2(3), 513-517.
31
[31] Mathar, I., Handayani, O. W. K., Widowati, E., & Zainafree, I. (2025). Analysis of the need for the development of a misconduct prevention system on National Health Insurance (JKN) claims at Hospital X. Procedia Environmental Science, Engineering and Management, 12(3), 1015-1030.
32
[32] Pribadi, F., Surwanti, A., & Shih, W. C. (2024). Hospital Funding System by Crowd Funding: A Start-Up Company. In International Congress on Information and Communication Technology (pp. 619-628). Singapore: Springer Nature Singapore.
33
[33] Johnson, S., & Antonio, F. (2024). The Interplay Between Hospital Operational Efficiency and Hospital Operational Benevolence and Its Relation to Hospital Performance in Private Hospital. In International Conference on Business and Technology (pp. 81-96). Cham: Springer Nature Switzerland.
34
[34] Agustine, F. E., Misnaniarti, M., & Idris, H. (2026). Geospatial analysis of hypertension control compliance and demographic factors among national insurance participants in Indonesia: An analysis based on national health insurance claims data. International Journal of Healthcare Management, 19(3), 514-519.
35
[35] Anggriani, Y., Ramadaniati, H. U., Sarnianto, P., Pontoan, J., & Suryawati, S. (2020). The impact of pharmaceutical policies on medicine procurement pricing in Indonesia under the implementation of Indonesia’s social health insurance system. Value in Health Regional Issues, 21, 1-8.